Literature DB >> 27067068

Long-term Follow-up of a Randomized Clinical Trial Assessing the Efficacy of a Brief Cognitive-Behavioral Depression Prevention Intervention for Caregivers with Elevated Depressive Symptoms.

Fernando L Vázquez1, Ángela Torres2, Vanessa Blanco3, Patricia Otero3, Olga Díaz4, María José Ferraces5.   

Abstract

OBJECTIVES: To evaluate the efficacy of a cognitive-behavioral intervention for the prevention of depression in caregivers with elevated depressive symptoms through 12 months of follow-up.
DESIGN: Randomized controlled trial.
SETTING: Community in Galicia (Spain). PARTICIPANTS: 170 caregivers with elevated depressive symptoms.
INTERVENTIONS: Caregivers were randomized to a cognitive-behavioral intervention (N = 88), administered to groups of five participants in five weekly 90-min sessions, or to a usual care control group (N = 82). MEASUREMENTS: Major depressive episodes (according to the Structured Clinical Interview for Axis I Disorders of the DSM-IV), depressive symptoms, emotional distress, caregiver burden, pleasant activities, depressive thoughts, social contacts. Trained blinded interviewers conducted assessments at 1, 3, 6, and 12 months of follow-up.
RESULTS: At the 12-month follow-up, there was a lower incidence of major depressive episodes in the intervention group compared with the control group (3.4% versus 22.0%). The relative risk was 0.15 (95% CI: 0.05-0.51) and the number needed to treat was 5 (95% CI: 3-11). The time of delay of the depressive episode onset in the intervention group was significant. Caregivers with good compliance to the intervention had a lower incidence of depression. The effects of the intervention on depressive symptoms, emotional distress, and caregiver burden were maintained for 12 months. Younger caregivers were more likely to benefit from the intervention. The change in depressive thoughts mediated the reduction in depressive symptoms.
CONCLUSIONS: Depressive episodes can be successfully prevented in caregivers, with long-term effects.
Copyright © 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cognitive-behavioral intervention; depression; indicated prevention; long-term follow-up; non-professional caregiver

Mesh:

Year:  2016        PMID: 27067068     DOI: 10.1016/j.jagp.2016.02.050

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  5 in total

1.  Feasibility and impact of a guided symptom exposure augmented cognitive behavior therapy protocol to prevent symptoms of pharmacologically induced depression: A pilot study.

Authors:  Lata K McGinn; Anna Van Meter; Ian Kronish; Jessica Gashin; Karen Burns; Natalie Kil; Thomas G McGinn
Journal:  Cognit Ther Res       Date:  2019-02-12

2.  Cognitive behavioral intervention via a smartphone app for non-professional caregivers with depressive symptoms: study protocol for a randomized controlled trial.

Authors:  Fernando L Vázquez; Ángela Torres; Olga Díaz; Mario Páramo; Patricia Otero; Vanessa Blanco; Lara López
Journal:  Trials       Date:  2018-07-31       Impact factor: 2.279

3.  Long-Term Effects of a Cognitive Behavioral Conference Call Intervention on Depression in Non-Professional Caregivers.

Authors:  Lara Lopez; Fernando L Vázquez; Ángela J Torres; Patricia Otero; Vanessa Blanco; Olga Díaz; Mario Páramo
Journal:  Int J Environ Res Public Health       Date:  2020-11-11       Impact factor: 3.390

4.  Psychometric Properties of the Spanish Version of the Caregiver Burden Inventory.

Authors:  Fernando L Vázquez; Patricia Otero; Miguel A Simón; Ana M Bueno; Vanessa Blanco
Journal:  Int J Environ Res Public Health       Date:  2019-01-14       Impact factor: 3.390

5.  Evaluation of a Caregiver-Friendly Workplace Program Intervention on the Health of Full-Time Caregiver Employees: A Time Series Analysis of Intervention Effects.

Authors:  Regina Ding; Anastassios Dardas; Li Wang; Allison Williams
Journal:  J Occup Environ Med       Date:  2020-10       Impact factor: 2.306

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.